UCB now has three core brands: Cimzia, for Crohn's disease and rheumatoid arthritis (RA), epilepsy treatment Vimpat and Neupro for Parkinson's disease. These three products are sustaining the firm ...
UCB SA (OTCMKTS:UCBJF – Get Free Report) was the target of a large growth in short interest in March. As of March 15th, there was short interest totalling 481,000 shares, a growth of 20.8% from the ...
December 12, 2018 – CEVA, Inc. (NASDAQ: CEVA), the leading licensor of signal processing platforms and artificial intelligence processors for smarter, connected devices, today announced that its ...
ROCKVILLE, Md., Dec. 13, 2022 -- CEVA, Inc. (NASDAQ: CEVA), the leading licensor of wireless connectivity and smart sensing technologies and co-creation solutions announced today that NeuPro-M AI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback